$RGLS Regulus Therapeutics Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Regulus Therapeutics Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Regulus Therapeutics Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Aker Christopher Ray | Sr. VP & General Counsel | 42,614 | 59,660 | Feb 17 2021 | |||
| ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | 4,896,716 | 6,855,402 | Feb 24 2016 | |||
| ASTRAZENECA PLC | 10% Owner | 4,250,000 | 5,950,000 | Nov 14 2014 | |||
| BALTIMORE DAVID | Director | 44,131 | 61,783 | Jun 19 2020 | |||
| BALTIMORE DAVID | Director | 0 | 0 | May 22 2014 | |||
| BARRIS PETER J | 10% Owner | 2,052,454 | 2,873,436 | Dec 26 2019 | |||
| BASKETT FOREST | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| Behbahani Ali | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| CALSADA CRISPINA | Chief Financial Officer | 0 | 0 | Feb 05 2021 | |||
| CARTER BRUCE L A | Director | 0 | 0 | Jun 26 2015 | |||
| CARTER BRUCE L A | Director | 0 | 0 | May 22 2014 | |||
| Chang Carmen | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| Chevallard Daniel R. | Chief Financial Officer | 77,870 | 109,018 | Jul 02 2019 | |||
| Collier Kathryn J | Director | 27,596 | 38,634 | Jun 19 2020 | |||
| CROOKE STANLEY T | Director | 7,049,500 | 9,869,300 | Nov 07 2012 | |||
| Deeg Mark Albert | Chief Medical Officer | 0 | 0 | May 21 2018 | |||
| Denner Alexander J | 10% Owner | 0 | 0 | Jan 03 2020 | |||
| Drygin Denis | Chief Scientific Officer | 0 | 0 | Aug 05 2020 | |||
| Florence Anthony A. Jr. | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| FOLETTA MARK G | Director | 81,910 | 114,674 | Dec 06 2017 | |||
| FOLETTA MARK G | Director | 0 | 0 | Jun 10 2013 | |||
| FOLETTA MARK G | Director | 0 | 0 | May 22 2014 | |||
| Gibson Neil W | Chief Scientific Officer | 80,000 | 112,000 | Jun 18 2014 | |||
| Gibson Neil W | Chief Scientific Officer | 80,000 | 112,000 | Jul 02 2014 | |||
| Gibson Neil W | Chief Scientific Officer | 0 | 0 | Jan 30 2015 | |||
| Gibson Neil W | Chief Scientific Officer | 80,000 | 112,000 | Oct 31 2014 | |||
| Greene Barry E | Director | 6,150,500 | 8,610,700 | Nov 07 2012 | |||
| GRINT PAUL C | President & CEO | 0 | 0 | Feb 23 2017 | |||
| GRINT PAUL C | Chief Medical Officer | 0 | 0 | Jun 18 2014 | |||
| GRINT PAUL C | Chief Medical Officer | 0 | 0 | Oct 22 2014 | |||
| GRINT PAUL C | Chief Medical Officer | 0 | 0 | Dec 04 2014 | |||
| Growth Equity Opportunities V, LLC | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| Hagan Joseph P | President and CEO | 320,478 | 448,669 | Apr 16 2021 | |||
| Huang Alice Shih-hou | Director | 0 | 0 | Jan 27 2021 | |||
| ISIS PHARMACEUTICALS INC | 10% Owner | 5,173,172 | 7,242,441 | Jul 17 2015 | |||
| Makhzoumi Mohamad | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| MAKOWER JOSHUA | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| MARAGANORE JOHN | Director | 6,150,500 | 8,610,700 | Oct 11 2012 | |||
| Menzel Garry E | COO & Executive VP, Finance | 0 | 0 | Dec 13 2012 | |||
| MOTT DAVID M | 10% Owner | 2,052,454 | 2,873,436 | Dec 26 2019 | |||
| Nunn Jason Raleigh | Director | 0 | 0 | Jun 19 2020 | |||
| PAPADOPOULOS STELIOS | Director | 1,986,729 | 2,781,421 | Dec 07 2020 | |||
| PAPADOPOULOS STELIOS | Director | 0 | 0 | May 22 2014 | |||
| PAPADOPOULOS STELIOS | Director | 150,000 | 210,000 | Dec 15 2014 | |||
| PARSHALL B LYNNE | Director | 7,049,500 | 9,869,300 | Oct 11 2012 | |||
| RASTETTER WILLIAM H | Director | 390,584 | 546,818 | Jun 19 2020 | |||
| RASTETTER WILLIAM H | Director | 0 | 0 | May 22 2014 | |||
| Rosen Hugh | Director | 22,756 | 31,858 | Jun 19 2020 | |||
| SANDELL SCOTT D | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| Sanofi | 10% Owner | 5,053,779 | 7,075,291 | Feb 05 2014 | |||
| Sarissa Capital Offshore Master Fund LP | 10% Owner | 0 | 0 | May 08 2020 | |||
| Simeonidis Simos | Director | 0 | 0 | Jun 19 2020 | |||
| Sonsini Peter W. | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| Szekeres David Leslie | CBO and General Counsel | 0 | 0 | Oct 22 2014 | |||
| Szekeres David Leslie | Chief Business Officer & GC | 0 | 0 | Dec 04 2014 | |||
| Walker Paul Edward | 10% Owner | 6,451,056 | 9,031,478 | Dec 07 2020 | |||
| WILLIAMS DOUGLAS E | Director | 0 | 0 | Jun 03 2016 | |||
| WILLIAMS DOUGLAS E | Director | 0 | 0 | May 22 2014 | |||
| Witz Pascale | Director | 37,849 | 52,989 | Jun 19 2020 | |||
| WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | 62,893 | 88,050 | Feb 06 2019 | |||
| XANTHOPOULOS KLEANTHIS G | President and CEO | 3,705 | 5,187 | Apr 21 2015 | |||
| XANTHOPOULOS KLEANTHIS G | President and CEO | 2,466 | 3,452 | Feb 03 2015 | |||
| XANTHOPOULOS KLEANTHIS G | President & CEO | 0 | 0 | Jun 09 2014 | |||
| XANTHOPOULOS KLEANTHIS G | President & CEO | 0 | 0 | Aug 29 2014 |